In this study, lymph node invasion was frequently described in patients with moderate- and high-risk RET mutations (53/127, 42%, and 48/135, 36%, respectively), but not distant metastatic disease (10/127, 8%, and 7/135, 5%, respectively). The gene discussed is RET; the disease is metastatic neoplasm.